This page lists all known medications that could potentially lead to 'Polymyositis' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...

Malnutrition was associated with poorer in-hospital outcomes among adults with DM/PM, including greater odds of in-hospital mortality and complications.

Please provide your email address to receive an email when new articles are posted on . Among systemic rheumatic diseases, the risk for opportunistic infection is highest among patients with ...

PF1801 is a novel long-acting glucagon-like peptide-1 receptor agonist. The Food and Drug Administration (FDA) has granted Orphan Drug designation to PF1801 for the treatment of polymyositis.

Belonging to the same group of autoimmune diseases, both dermatomyositis and polymyositis cause muscle inflammation and weakness. But dermatomyositis also affects your skin and is more likely to ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Many patients who might have previously been diagnosed with polymyositis are now being treated for ...

Systemic Lupus Erythematosus (SLE): SLE is an autoimmune disorder in which the immune system of the body attacks its own cells instead for fighting against foreign bacteria and other harmful ...

The alternative text for this image may have been generated using AI. New research from Tokyo, Japan could help clarify the role of proinflammatory mediators in the pathogenesis of chronic ...

Inflammatory myopathies are the largest group of potentially treatable myopathies in children and adults. They constitute a heterogeneous group of disorders that are best classified, on the basis of ...